That is alright Smach. Now, the question is how s

That is alright Smach. Now, the question is how soon and will this roll out of product be BioRemedies MD alone or will Dalton say something or maybe even a word or two from both. Following that we need the financials or some other indication of forward movement. As a shareholder, I don't think that is too much to ask.


Kgem